Karen Rogers

All Posts

  • 3 Free Falling Stocks To Short

    By Karen Rogers - September 24, 2012 | Tickers: HGG, P, SVU

    When a company is unable to turn itself around and hits that point of no return, investors can ride the stock down and make some nice profits.  Those with an appetite for thrills will sell the stock short or, for a more conservative play, buy option puts to contain the risk.

    Despite operating 212 stores in 17 states, hhgregg’s (NYSE: HGG) operating income is the same as it was more »

  • Safe Investing In Apple’s Newest Friends

    By Karen Rogers - September 24, 2012 | Tickers: AAPL, BIDU, YNDX

    The champagne corks were popping in Cupertino when Apple’s (NASDAQ: AAPL) stock broke the $700 barrier in after-hours trading.  Apple has now joined a very elite group of companies that have achieved this distinction, and it’s a short list that includes Google at $703 a share, NVR at $864 a share, and Central Steel & Wire at $725 a share. But Apple’s upward momentum shows little sign of more »

  • 3 Great Cyber Security Stock Plays

    By Karen Rogers - September 22, 2012 | Tickers: BAH, CACI, KEYW

    In April, 2009, Chinese and Russian cyberspies hacked their way into the U.S. electrical grid and left a malware gift designed to shut the grid down.  In November, 2011, a hacker easily hacked the Siemens three character password, gaining access into a South Houston waste water treatment plant’s Siemens Simatic HMI (human machine interface) software.  And the Cyber Security Act of 2012, possibly the most important piece of more »

  • Immortality and 3 Stem Cell Research Stocks

    By Karen Rogers - September 21, 2012 | Tickers: BAX, NBS, OSIR

    Stem cell research puts immortality in our hands.  By medically treating stem cells to repair damaged organs, one could, in theory, live forever.  The following three stem cell research companies are achingly close to perfecting techniques that will repair and strengthen damaged human hearts.         

    Osiris Therapeutics’ (NASDAQ: OSIR) Prochymal is the only drug that’s been granted fast track status and Orphan Drug status by the FDA.  Already in Phase more »

  • Will REITs Kiss High Dividends Goodbye?

    By Karen Rogers - September 20, 2012 | Tickers: AGNC, NLY, CMO

    Ben Bernanke’s decision to go ahead with the newest round of quantitative easing was bad news for some market sectors.  During the recent FOMC meeting, the Federal Reserve announced they would continue to keep long-term interest rates low by purchasing an additional $40 billion dollars’ worth of agency mortgage-backed securities in addition to the $25 billion per month the Fed was already buying.

    But just what is the Federal more »

  • Apple’s Newest Suppliers-Should You Invest?

    By Karen Rogers - September 17, 2012 | Tickers: AAPL, MU, TOSBF

    With Samsung (SSNLF) being phased out of Apple’s (NASDAQ: AAPL) universe, a new crop of component suppliers has come on board.  Apple is the world’s leading chip buyer and these companies should be kept busy producing enough chips to meet the tech giant’s demands.  The financial health of the three companies Apple selected to replace Samsung is summarized in the following chart.

     

    Toshiba

    Elpida Memory

    SK Hynix more »

  • Hewlett-Packard and the Gathering Shorts

    By Karen Rogers - September 14, 2012 | Tickers: DELL, HPQ, IBM, MSFT

    If I hadn’t come across Hewlett-Packard’s (NYSE: HPQ)  announcement that the company had just released four new computers, I never would have known.  The computers are part of Hewlett Packard’s AiO, or all-in-one line, which uses touch screen and one cord technologies.

    What did catch my eye, however, was news that HP was firing 29,000 employees instead of the estimated 26,000.  Last week Dell (NASDAQ: DELLmore »)

  • 3 Holiday Short Squeeze Plays

    By Karen Rogers - September 14, 2012 | Tickers: GME, JCP, ZAGG

    Selling a stock short is a lot like bungee jumping—it’s great so long as the line doesn’t snap or the market turn against you.

    The problem with short selling is that sooner or later, no matter how terrible the company may be, the stock will bounce back up due either to a new bull rally or even a “dead cat bounce” before the stock resumes its downward more »

  • Why Samsung Doesn’t Need Apple

    By Karen Rogers - September 14, 2012 | Tickers: AAPL, GOOG, SHCAY.PK

    Right about now, Apple (NASDAQ: AAPL) should be regretting their decision to attack Google (NASDAQ: GOOG) through Samsung.  The glow from that $1 billion dollar judgment against Samsung must have faded now that Apple realizes that, instead of shutting down Google’s Android, they’ve created a new rival.

    It’s easy to think of Samsung as just an Android handset producer.  According to the International Data Corporation (IDC) Worldwide more »

  • Slaying the Alzheimer Demon

    By Karen Rogers - September 13, 2012 | Tickers: BAX, ELN, PFE, RHHBY

    This morning a husband woke up and couldn’t recognize his wife’s face.  An elderly mother stares blankly at her daughter, vainly trying to remember her child’s name. 

    This is the evil of Alzheimer’s, an insidious disease which robs families and friends of their loved ones while they’re still alive.  According to the Alzheimer Association, it will afflict more than 5.4 million Americans this year more »

  • Facebook: Zuckerberg’s Unanswered Questions

    By Karen Rogers - September 12, 2012 | Tickers: FB, GOOG, ZNGA

    “We don’t build services to make money; we make money to build great services.”

    In that one sentence, CEO and Founder Mark Zuckerberg summed up why Facebook (NASDAQ: FB) will never achieve the profit investors expect. I listened to the entire TechCrunch Disrupt interview with interest, and a brief summary of Mr. Zuckerberg’s thoughts and answers to some very important questions and concerns are summarized below.   

    What is more »

  • Companies Ready for Acquisition

    By Karen Rogers - September 9, 2012 | Tickers: DNDN, LEAP, MU

    Sometimes when bad things happen, good companies can find themselves unable to recover their former glory.  Although the reasons may be different, the companies analyzed here have become very attractive to investors looking for acquisition candidates.

    In April 2010, FDA approval of Provenge drove Dendreon’s (NASDAQ: DNDN) shares to a company high of $57.67.  Provenge therapy was designed to “teach” the human immune system to recognize and eliminate more »

  • These Stocks Make RIMM Look Good

    By Karen Rogers - September 9, 2012 | Tickers: ANR, NIHD, SVU

    Research in Motion is the Rodney Dangerfield of the tech world.  Missed opportunities, product delays and a general Keystone Kops atmosphere have combined to drive the company to its knees.

    But sad as that might be, there are some dogs out there that make RIMM look stellar.  The following stocks have lost more than 60% of their stock price this year, are awash in debt, and have a substantial amount more »

  • Safe High Yielding Stocks To Hold Forever

    By Karen Rogers - September 9, 2012 | Tickers: AVA, ED, WGL

    These are the stocks your father wanted you to buy.  They’re not glamorous techs or flashy metals and the mere mention of their names starts a yawn festival.  But while Silicon Valley’s dot.coms were flashing then crashing followed by the housing market’s nosedive, these old-fashioned utilities kept right on paying boring dividends and making their investors richer. 

    WGL Holdings (NYSE: WGL) has been paying dividends for more »

  • Investors Beware: One Trick Pony Stocks Ahead

    By Karen Rogers - September 7, 2012 | Tickers: AAPL, BBW, CRUS, SWKS

    There’s a reason that future business managers and CEOs are taught the virtue of diversification.  Offering a variety of products to a roster of clients maximizes profit potential and provides revenue insulation should a company lose customers.  Unfortunately, this lesson can be forgotten when your biggest client is a major market mover and a primary source of revenue.

    Cirrus Logic (NASDAQ: CRUS) supplies chips that are used in Apple more »

  • $1000 Reasons Why Apple Needs China Mobile

    By Karen Rogers - September 6, 2012 | Tickers: AAPL, CMGE, QCOM

    China: the final frontier.  These are the voyages of the tech giant, Apple (Nasdaq: AAPL).  Its mission: to give investors a second chance to make new profits, to scale trade barriers with the new iPhone 5; and to boldly go where their stock price hasn’t gone before.

    With apologies to Gene Roddenberry, China holds the key to Apple’s continued growth.  At present, Apple has captured about 15% of more »

  • iPhone 5: How China’s Mobile Carriers Stack Up

    By Karen Rogers - September 6, 2012 | Tickers: AAPL, CMGE, CHA, CHU

    With preorders starting on September 15th and an anticipated release date of October 12th, Apple (NASDAQ: AAPL) is looking for the iPhone 5 to jump-start its presence in the Chinese mobile telecom market.

    Apple’s iPhone success varies with each of China’s big three carriers.  China Mobile’s 3G network remains a major barrier to Apple as the iPhone isn’t compatible with this network.  China Unicom more »

  • Facebook’s Pseudo Stock Buyback

    By Karen Rogers - September 6, 2012 | Tickers: FB, GOOG, YHOO

    When is a stock buyback not a stock buyback?  When it’s a Facebook (NASDAQ: FB) buyback, of course!

    Facebook’s announcement on Wednesday of a “massive” $2 billion dollar stock buyback is pure Zuckerspeak.  Facebook did no such thing.  Holding back on employee stock distributions and Mr. Z promising not to sell his stock for a year is not a buyback.

    Facebook had already earmarked 234 million stock shares more »

  • Avoid These 3 Stocks Drowning In Debt

    By Karen Rogers - September 6, 2012 | Tickers: CAR, BG, NAT

    Taking on debt to finance company operations is fine unless management allows that debt to grow unchecked.  Although in different industries, each of the three companies analyzed below suffer from the same problem: too much debt. 

    Enter Nordic American Tankers (NYSE: NAT), sinking under the weight of an aging fleet, negative cash flow, and unsustainable dividend payments.  Eleven out of Nordic American’s twenty tankers are just about ready for more »

  • Mining New Profits In Copper’s Rebound

    By Karen Rogers - September 5, 2012 | Tickers: FCX, SSLT, SCCO

    Although copper has been hit hard by the world economic slowdown and general financial malaise, it has fared somewhat better than other non-precious metals.  Along with the housing industry, copper is required for making the vital components and wiring needed to meet rising tech and electronic demands.  The London Metal Exchange reports copper inventories are at their lowest levels since the beginning of June this year.  Amid scarcity concerns, three more »

  • Page 1 of 5